Results 251 to 260 of about 1,622,130 (371)

Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background The diagnosis of inclusion body myositis (IBM) can be delayed because of its heterogeneous clinical presentation and the lack of specific biomarkers. Muscle imaging has gained increasing relevance over the past decade and is now included among the supportive criteria in the international diagnostic guidelines.
Eleonora Torchia, Matteo Lucchini, José Verdu‐Diaz, Sara Bortolani, Beatrice Ravera, Vincenzo Carlomagno, Alessandra Cicia, Daniela Bernardo, Mauro Monforte, Robert Rehmann, Rudolf Andre Kley, Mario Sabatelli, Jordi Díaz‐Manera, Enzo Ricci, Massimiliano Mirabella, Giorgio Tasca   +15 more
wiley   +1 more source

Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment. [PDF]

Rheumatol Adv Pract
Loh K, Rose E, Tansley S.
europepmc   +1 more source

Clinical Significance of Abnormal Serum LGALS3BP Expression in Patients with Idiopathic Inflammatory Myopathies

Liuyi Huang, Xiaoxia Huang, Wei Zhou, Yanting Jiang, Haiqing Zhu, Yuehong Lao, Zhenjia Deng, Yuting Tang, Jian Wang, Xi Li   +9 more
openalex   +2 more sources

Rituximab in Patients with Inflammatory Myopathies [PDF]

, 2013
Seong Wook Kang
openalex   +1 more source

Pulmonary Obstruction and Age, Not Activity, Associate With Muscle Oxidative Impairment in Smokers With and Without COPD

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Low muscle oxidative capacity is an extrapulmonary manifestation of chronic obstructive pulmonary disease (COPD) with unclear aetiology. We sought to characterize locomotor muscle oxidative capacity in never smokers and ever smokers with and without COPD and determine clinical and behavioural features associated with low muscle ...
Alessandra Adami, Fenghai Duan, Robert A. Calmelat, Zeyu Chen, Richard Casaburi, Harry B. Rossiter   +5 more
wiley   +1 more source

Immune Characterization of a Vietnamese Cohort With Idiopathic Inflammatory Myopathies. [PDF]

Muscle Nerve
Luo YB, Nakazawa M, Minh NPT, Heinon L, Nennesmo I, Rönnelid J, Lundberg IE, Phuong TNT, Horuluoglu B.   +8 more
europepmc   +1 more source

Direct AMPK Activation Confers Mutation‐Independent Therapeutic Benefit in Duchenne Muscular Dystrophy

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Duchenne muscular dystrophy (DMD) is a severe, life‐limiting neuromuscular disorder (NMD) characterized by progressive muscle wasting and mitochondrial dysfunction. Although gene therapies offer promise, even those already approved by regulatory agencies, their use remains constrained by mutation specificity, delivery challenges and
Sean Y. Ng, Andrew I. Mikhail, Stephanie R. Mattina, Magda A. Lesinski, Irena A. Rebalka, Sophie I. Hamstra, Donald Xhuti, Val A. Fajardo, Mark A. Tarnopolsky, Joshua P. Nederveen, Gregory R. Steinberg, Thomas J. Hawke, Vladimir Ljubicic   +12 more
wiley   +1 more source

Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study. [PDF]

Rheumatology (Oxford)
Kastrati K, Karonitsch T, Rajab H, Reindl-Schwaighofer R, Eskandary F, Pajenda S, Mrak D, Heil PM, Kiener HP, Bonelli M, Derfler K, Aletaha D, Smolen JS, Radner H.   +13 more
europepmc   +1 more source

Associated Factors for the Occurrence of Rapidly Progressive Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myopathies: A Systematic Review and Meta-analysis [PDF]

Weiwei Yuan, Xuefei Zhou, Yahui Yang, Shijie Zhang, Xing He, Jiaqi Ji   +5 more
openalex   +1 more source

Largely Distinct Post‐Translational Modifications Differentiate Skeletal Muscle Wasting Caused by Cancer, Dexamethasone and Aging

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Skeletal muscle wasting and weakness are prominent disease features. Originally considered to arise from common transcriptional changes, recent analyses demonstrated that different stimuli induce muscle wasting via largely distinct mRNA and protein changes.
Anna Stephan, Flavia A. Graca, Suresh Poudel, Yingxue Fu, Yong‐Dong Wang, Myriam Labelle, Fabio Demontis   +6 more
wiley   +1 more source